Skip to main content
Clinical Trials/IRCT2016092624021N2
IRCT2016092624021N2CompletedPhase 2

Evaluation of the effect of levothyroxine in comparison to placebo on thyroid nodule volume in patients with benign thyroid nodule during 2 year follow up

Guilan University of Medical Sciences, Vice chancellor for research0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 60 years (—)
Sex
All

Inclusion Criteria

  • patiens with single or multi thyroid nodules that have been proved to be benign with FNA
  • Exclusion criteria:age under 20 and over 60; hypo or hyper thyroidism; history of using levothyroxine during past year; osteoporosis ; pregnancy; cardiovascular disease

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Guilan University of Medical Sciences, Vice chancellor for research

Similar Trials